Alternatives to Arc Institute

AI-powered platform for designing novel molecular structures for new medicines.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

Vivodyne is developing advanced AI models for drug discovery and development.

AI-powered platform accelerating biological research and drug discovery.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI-driven platform for protein-level disease mapping and drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Perscient reveals AI-powered human insight into the narratives driving your business.

AI platform for accelerating novel peptide therapeutic discovery and development.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Advance every cancer decision.

AI-driven predictive modeling company focused on biology and life sciences.

AI-powered insights platform for life sciences and biotech workflows.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

AI platform for computational biologists to accelerate drug discovery and therapeutic development.

One Biosciences is a French biotech startup leveraging single-cell multi-omics and AI to discover novel drug targets for complex diseases.

Building General Biological Intelligence

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

Academic institute for applied computational health research in Israel.

Cloud-based platform for reproducible computational research in life sciences.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

AI-enabled technology for cell biology research and biopharma development.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

A unified data analytics and AI platform built on the lakehouse architecture.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.